Good morning, trader! We’re starting off the day with a dive into the biggest pre-market stock movers for Thursday.
There’s a lot of reason for stocks to be moving today. from earnings reports to clinical trial data, and with that comes winners and losers.
Let’s get into those pre-market stock movers below!
Pre-Market Stock Movers: 10 Top Gainers
- Cardiff Oncology (NASDAQ:CRDF) stock is soaring more than 20% .
- PharmaCyte Biotech (NASDAQ:PMCB) shares are rising over 16 % .
- Lululemon Athletica (NASDAQ:LULU) stock is gaining more than 14 % .
- ProQR Therapeutics (NASDAQ:PRQR) shares are climbing over 13 % (NYSE:LLY).
- Hyzon Motors (NASDAQ:HYZN) stock is sitting more than 10 % higher as it recovers from a fall yesterday.
- Comstock Mining (NYSEAMERICAN:LODE) shares are increasing over 8% .
- Gold Royalty (NYSEAMERICAN:GROY) stock is jumping more than 8% .
- BeyondSpring (NASDAQ:BYSI) shares are getting an over 7 % boost .
- Aethlon Medical (NASDAQ:AEMD) stock is heading more than 6% higher .
- Direxion Daily FTSE China Bear 3x Shares (NYSEARCA:YANG) are up over 6% this morning.
10 Top Losers
- Humanigen (NASDAQ:HGEN) stock is diving more than 55% .
- Helbiz (NASDAQ:HLBZ) shares are taking a more than 19% beating .
- Direxion Daily CSI China Internet Index Bull 2X Shares (NYSEARCA:CWEB) are falling over 8%
- Certara (NASDAQ:CERT) stock is dropping more than 7% .
- HUYA (NYSE:HUYA) shares are decreasing over 7%, which continues negative movement from yesterday.
- Huize Holding (NASDAQ:HUIZ) stock is slipping more than 7% .
- DouYu International Holdings (NASDAQ:DOYU) shares are declining over 7% as it continues a fall from Wednesday.
- Arqit Quantum (NASDAQ:ARQQ) stock is dipping close to 7% after a rally on the previous day of trading.
- Bilibili (NASDAQ:BILI) stock is sitting more than 6% lower on no clear news this morning.
- GameStop (NYSE:GME) shares close out the pre-market stock movers down over 6% .
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.